Hi Everyone,

It has been a very long time since I posted. For those who don¹t know me and
all the rest, I will bring you up to date. I am somewhere between #149 and
#156 in Zavie¹s club.

I was dx in 1999 and put on interferon and ARAC. I had bad reactions and
joined the intolerant STI571 trial at Dana Farber. I continued my treatment
there until we moved from PA to FL. I was also in the vaccine trial in 2003
at UCONN. 

When we got to FL, I was very lucky to find a wonderful onc. He decided he
wanted my bone marrow tests run on a fresh sample so he sends me to MDACC.

I remain on 400mg of Gleevec. I just got my last bma results from Dec. and I
am at .02. The lowest I have been ever is .01. It kind of bounces around. I
will go back to MDACC in June and if everything stays stable I will only
need to go back once a year.

It seems so hard to realize that when I was dx I had a prognosis of 3-5
years if I was lucky. I watched many brave warriors lose their battles and
am so pleased it is not so common now.

My biggest problem now is that they found I have BRAC2. I had my ovaries
removed last spring and now I have an appointment with the breast surgeon.
All of my docs are insisting on a double mastectomy. The most interesting
thing about this is it is related to melanoma, which explains why my first
on was in my armpit where the sun never shone.

Moving to Fl was a very good decision for us. We are very active and have
found a nice group of friends. It is a wonderful blessing to not have one¹s
life ruled by illness.

Best to all, 

Judy L

(cross posted)

--~--~---------~--~----~------------~-------~--~----~
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------

You received this message because you are subscribed to the Google Groups 
"CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to 
[email protected]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---

Reply via email to